Laura Adams

Senior Advisor, National Academy of Medicine (NAM)
Panelist

Laura Adams, Senior Advisor at the National Academy of Medicine (NAM) leads the NAM’s Artificial Intelligence Code of Conduct (AICC) national initiative. Her expertise is in digital health, the science of improvement, and human-centered care. Laura serves on the boards of Boston-based T2 Biosystems and TMA Precision Health; and the Coalition for Health AI (CHAI) Steering Committee. She is a strategic advisor for Inflammatix, a Burlingame, CA-based biotech company specializing in transcriptomics/host immune response diagnostics. Laura was founding President and CEO of the Rhode Island Quality Institute (RIQI), one of the nation’s first statewide health information exchanges/health data repositories in the U.S. Under her leadership, RIQI won the National Council for Community Behavioral Health Excellence Award for Impact in serving those with behavioral health and substance abuse challenges and was the recipient of the national 2018 Healthcare Informatics Innovation Award for impact on the opioid crisis. 

Laura Adams